MICHAEL POLO: Open Payments
NPI 1942347257 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,564 in 108 payments from 17 companies in 2025. Trend: 2023 $452 · 2024 $1,063 · 2025 $2,564
Food & beverage: $2,459Education: $104
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $520 |
| Teva Pharmaceuticals USA, Inc. | 10 | $310 |
| ABBVIE INC. | 24 | $288 |
| Axsome Therapeutics, Inc. | 13 | $262 |
| Otsuka America Pharmaceutical, Inc. | 7 | $229 |
| Vanda Pharmaceuticals Inc. | 8 | $170 |
| Alkermes, Inc. | 7 | $153 |
| Brainsway USA INC | 1 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Almatica Pharma LLC | 5 | $90 |
Products named: COBENFY, VRAYLAR, REXULTI, AUSTEDO XR, Auvelity, FANAPT, Deep TMS, ARISTADA.
Industry payments across CA — which companies pay providers there.
